熱門資訊> 正文

PAVmed宣布1比30反向股票拆分

2025-12-30 22:29

PAVmed (PAVM) will conduct a 1-for-30 reverse stock split of its common stock, effective on January 2, 2026, at 12:01 a.m. Eastern Time.
The reverse stock split is intended to bring the company into compliance with the $1.00 minimum bid price requirement for maintaining the listing of its common stock on Nasdaq.
Following the split, the authorized shares of common stock will be reduced from 250M to 25M.
PAVM -11.72% premarket to $0.25.
Source: Press Release

More on PAVmed, Lucid Diagnostics

PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript
Lucid Diagnostics Inc. 2025 Q3 - Results - Earnings Call Presentation
PAVmed Inc. 2025 Q3 - Results - Earnings Call Presentation
Lucid Diagnostics signals imminent Medicare coverage for EsoGuard while strengthening commercial payer engagement
PAVmed Q3 2025 Earnings Preview

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。